Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...

Global High Potency API CDMOs Market OverviewThe global high potency active pharmaceutical ingredient (HPAPI) CDMOs market is ...

Zhejiang Hengkang Pharmaceutical Co., Ltd. continues to strengthen its position as a leading manufacturer within the global active pharmaceutical ingredient industry, attracting growing attention for ...

Companies in India, China, and Europe continue to play an outsized role in manufacturing active pharmaceutical ingredients (API) used in products destined for the US market in terms of locations cited ...

When the campus is complete, it will produce several of Lilly’s APIs and genetic medicines to serve US patients.

Procurement frameworks now incorporate resilience criteria, enabling tender preference for diversified, Europe-based manufacturing and contingency capacity over lowest price, reshaping economics for ...